Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Rozzano
Clinical trial register · Italy

Clinical Trials in Rozzano, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 21 Rozzano 18 Rome 15 Bologna 14 Roma 12

Trials with a site in Rozzano

18 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 2
100
Bologna, Rozzano
2026-03-24
Recruiting
Eli Lilly and Company
Phase 2
252
Milan, Roma, Rozzano
2025-11-10
Recruiting
Genentech, Inc.
Phase 2
224
Rome, Brescia, Milan, Pavia, Rho, Rozzano, San Donato Milanese (MI), Turin
2025-09-29
Recruiting
Eli Lilly and Company
Phase 3
350
Bologna, Castellana Grotte, Milan, Padova, Pisa, Rho, Roma, Rozzano
2025-06-26
Active, closed
AbbVie
Phase 3
573
Monserrato, Rozzano, Milan, Naples, Rome, Bologna, Padova, Palermo
2025-06-17
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Castellana Grotte, Pavia, Legnano, Rozzano, San Donato Milanese, Segrate, Turin, Bologna
2025-05-27
Not yet open
Istituto Clinico Humanitas
Observational
174
Rozzano
2024-07-31
Active, closed
Takeda
Phase 2
213
Bologna, Milan, Palermo, Rome, Rozzano
2024-03-29
Active, closed
Gilead Sciences
Phase 2
176
Catanzaro, Milan, Roma, Rozzano
2023-12-05
Active, closed
AnaptysBio, Inc.
Phase 2
132
Bologna, Cagliari, Catania, Legnano, Milan, Pavia, Rozzano, San Donato
2023-12-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Monserrato, San Giovanni Rotondo, Rome, Milan, Rozzano, Rho, Naples, Palermo
2023-10-25
Active, closed
Alfasigma S.p.A.
Observational
509
Bari, Milan, Pisa, Negrar, Palermo, Rozzano, Torino
2023-06-12
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
Abivax S.A.
Phase 3
1,116
San Giovanni Rotondo, Rho, Rozzano, San Donato Milanese, Negrar, Alessandria, Bologna, Brescia
2023-01-16
Active, closed
AbbVie
Observational
785
Castellana Grotte, Rozzano, Milan, Naples, Rome, Negrar, Palermo, Pisa
2022-08-15
Active, closed
Abivax S.A.
Phase 2
203
Roma, Rozzano, Verona
2021-12-03
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Bologna, Milan, Negrar, Padova, Palermo, Rho, Roma, Rozzano
2019-09-26
Active, closed
Eli Lilly and Company
Phase 3
1,058
Catanzaro, Genova, Pisa, Rho, Roma, Rome, Rozzano, Torino
2018-07-18
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-italy/city/rozzano

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Rozzano that also match the filters currently applied.

How many clinical trials are recruiting in Rozzano?

6 of the 18 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Rozzano), 18 studies
PhaseStudiesRecruitingShare
Phase 28444.4%
Phase 36233.3%
Observational3016.7%
Phase 2/3105.6%

Most active sponsors

Lead sponsors with the most studies (Rozzano)
Lead sponsorStudiesRecruiting
Eli Lilly and Company32
AbbVie20
Abivax S.A.20
Merck Sharp & Dohme LLC21
Alfasigma S.p.A.10
AnaptysBio, Inc.10
Genentech, Inc.11
Gilead Sciences10
Istituto Clinico Humanitas10
Janssen Research & Development, LLC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.